Senate Amendment 1 to Senate Bill 194
152nd General Assembly (2023 - 2024)
Bill Progress
Passed 3/28/24
The General Assembly has ended, the current status is the final status.
Bill Details
3/28/24
This Amendment does the following:
1. It clarifies the requirement for training required prior to the first time a pharmacist initiates therapy under this Act.
2. It changes the language for the type of negative test required to make it a test that is approved by the U.S. FDA.
3. It clarifies the requirements for action to be taken if a patient tests positive and adds the requirement, if approved by the patient, to send the test results to a primary care provider if the patient has one.